Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06833 SINCO PHARMA
RT Nominal up0.190 +0.002 (+1.064%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties6,139-2.849%6,3196,4996,6797,133
Property, plant, equip. & others279,0838.126%258,109207,867188,249196,993
Land & other Lease Assets75,12530.132%57,73048,39449,9341,041
Intangible Assets93,64514.850%81,53702245
Interests in Asso. & JCEs0--0000
Other Non-current Assets3,4035.291%3,2321,0291,4421,229

457,39512.402%406,927263,789246,326206,441
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories108,02622.551%88,14861,270242,561259,266
Trade Receivables540,50553.873%351,268213,601578,68730,710
Cash & Bank Balances437,92233.049%329,144326,052143,765219,755
Other Current Assets346,83039.375%248,846368,05440,714116,172
Assets Held for Sale0--0000

1,433,28340.876%1,017,406968,9771,005,727625,903
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables866,585112.405%407,988422,933700,320300,466
S-T Debt & Leases244,69033.126%183,804208,70478,722188,506
Other Current Liabilities120,762-39.252%198,79393,999211,751166,819
Liab asso w/ Assets Held for Sale0--0000

1,232,03755.839%790,585725,636990,793655,791
Net Current Assets201,246-11.275%226,821243,34114,934(29,888)
Total Assets Less Current Liabilities658,6413.928%633,748507,130261,260176,553
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases6,711-22.038%8,608132,2443,409154
Other Non-current Liabilities23,87811.956%21,328093,422130,107

30,5892.181%29,936132,24496,831130,261
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital1640.000%164151136136
  Reserves627,8884.016%603,648374,735165,20147,064
  Others0--0000
Shareholders' Funds628,0524.014%603,812374,886165,33747,200
Non-controlling Interests0--00(908)(908)
Others0--0000

628,0524.014%603,812374,886164,42946,292
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments18,961-58.473%45,66085,26483,00883,008
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 13/11/2024 17:49
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 23,870
%Change21.817%
EPS / (LPS)RMB 0.012
NBV Per Share (¥)RMB 0.317
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.